C6-NBD Sphingomyelin
Manufacturer: Sigma Aldrich
CAS Number: 94885-04-8
Synonym(S): N-[6-[(7-nitro-2-1,3-benzoxadiazol-4-yl)amino]hexanoyl]-sphingosine-1-phosphocholine
Select a Size
| Pack Size | SKU | Availability | Price |
|---|---|---|---|
| 1 MG | 810218C-1-MG | In Stock | ₹ 54,449.55 |
810218C - 1 MG
In Stock
Quantity
1
Base Price: ₹ 54,449.55
GST (18%): ₹ 9,800.919
Total Price: ₹ 64,250.469
Assay
>99% (TLC)
form
liquid
packaging
pkg of 1 × 1 mL (810218C-1mg)
manufacturer/tradename
Avanti Polar Lipids 810218C
concentration
1 mg/mL (810218C-1mg)
shipped in
dry ice
storage temp.
−20°C
InChI
1S/C35H61N6O9P/c1-5-6-7-8-9-10-11-12-13-14-15-16-18-21-32(42)30(28-49-51(46,47)48-27-26-41(2,3)4)37-33(43)22-19-17-20-25-36-29-23-24-31(40(44)45)35-34(29)38-50-39-35/h18,21,23-24,30,32,42H,5-17,19-20,22,25-28H2,1-4H3,(H2-,36,37,39,43,46,47)/b21-18+/t30-,32+/m0/s1
InChI key
YDBDYTGWMRUUSN-PERJAUJZSA-N
Other Options
| Image | Product Name | Manufacturer | Price Range | |
|---|---|---|---|---|
 | C6-NBD Sphingomyelin | Sigma Aldrich | ₹ 59,775.65 | |
 | 94885-04-8 | N-[6-[(7-nitro-2-1,3-benzoxadiazol-4-yl)amino]hexanoyl]-sphingosine-1-phosphocholine | A2B Chem | ₹ 70,672.56 |
Related Products
Description
- General description: C6-NBD Sphingomyelin is a fluorescent derivative of sphingomyelin. Its fluorescent property is due to presence of NBD (2-(4-nitro-2,1,3-benzoxadiazol-7-yl) aminoethyl) group.[1] Sphingomyelin is generally concentrated in the outer leaflet of the plasma membrane.[2]
- Application: C6-NBD Sphingomyelin is suitable to study sphingomyelin endocytosis using fluorescence microscopy.[3]
- Biochem/physiol Actions: Sphingomyelin (SM) is involved in signal transduction and membrane trafficking. It is synthesized by the transfer of phosphocholine from phosphatidylcholine onto ceramide, catalysed by sphingomyelin synthase on the cell surface and in lumen of the Golgi. SM has high packing density and affinity for sterol which offer a strong barrier to extracellular environment.[2]
- Packaging: 5 mL Amber Glass Screw Cap Vial (810218C-1mg)
SAFETY INFORMATION
Pictograms
Signal Word
Danger
Hazard Statements
Precautionary Statements
P201 - P273 - P301 + P312 + P330 - P302 + P352 - P304 + P340 + P311 - P308 + P313
Hazard Classifications
Acute Tox. 3 Inhalation - Acute Tox. 4 Oral - Aquatic Chronic 3 - Carc. 2 - Eye Irrit. 2 - Repr. 2 - Skin Irrit. 2 - STOT RE 1 - STOT SE 3
Target Organs
Central nervous system, Liver,Kidney
WGK
WGK 3
Compare Similar Items
Show Difference
Assay: >99% (TLC)
form: liquid
packaging: pkg of 1 × 1 mL (810218C-1mg)
manufacturer/tradename: Avanti Polar Lipids 810218C
concentration: 1 mg/mL (810218C-1mg)
shipped in: dry ice
storage temp.: −20°C
InChI: 1S/C35H61N6O9P/c1-5-6-7-8-9-10-11-12-13-14-15-16-18-21-32(42)30(28-49-51(46,47)48-27-26-41(2,3)4)37-33(43)22-19-17-20-25-36-29-23-24-31(40(44)45)35-34(29)38-50-39-35/h18,21,23-24,30,32,42H,5-17,19-20,22,25-28H2,1-4H3,(H2-,36,37,39,43,46,47)/b21-18+/t30-,32+/m0/s1
InChI key: YDBDYTGWMRUUSN-PERJAUJZSA-N
Assay: >99% (TLC)
form: powder
packaging: pkg of 1 × 1 mg (810218P-1mg)
manufacturer/tradename: Avanti Polar Lipids 810218P
concentration: __
shipped in: dry ice
storage temp.: −20°C
InChI: 1S/C35H61N6O9P/c1-5-6-7-8-9-10-11-12-13-14-15-16-18-21-32(42)30(28-49-51(46,47)48-27-26-41(2,3)4)37-33(43)22-19-17-20-25-36-29-23-24-31(40(44)45)35-34(29)38-50-39-35/h18,21,23-24,30,32,42H,5-17,19-20,22,25-28H2,1-4H3,(H2-,36,37,39,43,46,47)/b21-18+/t30-,32+/m0/s1
InChI key: YDBDYTGWMRUUSN-PERJAUJZSA-N
Assay: >99% (TLC)
form: powder
packaging: pkg of 1 × 1 mg (810219P-1mg)
manufacturer/tradename: Avanti Polar Lipids 810219P
concentration: __
shipped in: dry ice
storage temp.: −20°C
InChI: __
InChI key: __
